Up next

Autoplay

Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL

9 Views • 08/09/23
Share
Embed
administrator
administrator
Subscribers
0

Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay